Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (491-500 of 568) with videos related to

Pageof 57
Sort By:
The American Journal of Gastroenterology|January 31, 2025
HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA RegistryMargalida Calafat, Carles Suria, Francisco Mesonero, et al.
The American Journal of Gastroenterology|November 26, 2024
Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study)María José García, Yanire Brenes, Miren Vicuña, et al.
Gastroenterologia Y Hepatologia|November 25, 2023
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)Diego Casas Deza, Ana Belén Julián Gomara, Eva Caudevilla Biota, et al.
Scandinavian Journal of Gastroenterology|October 22, 2010
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)Miguel A Montoro, Lawrence J Brandt, Santos Santolaria, et al.
Journal of Crohn'S & Colitis|November 20, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Stefanos Bonovas, Tim Raine, et al.
Journal of Clinical Medicine|July 2, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Joshua Taylor, Edoardo V Savarino, et al.
Digestive Diseases and Sciences|July 17, 2020
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA RegistryAlicia Algaba, Iván Guerra, Elena Ricart, et al.
Journal of Crohn'S & Colitis|October 9, 2025
Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkersMontse Baldán-Martín, Ibon Iloro, Mikel Azkargorta, et al.
Gastroenterologia Y Hepatologia|January 14, 2024
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)Diego Casas Deza, Ana Belén Julián Gomara, Eva Caudevilla Biota, et al.
The American Journal of Gastroenterology|July 15, 2024
HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study of the ENEIDA registryMargalida Calafat, Carles Suria, Francisco Mesonero, et al.
Pageof 57

Showing results (491-500 of 568) with videos related to

Sort By:
Pageof 57
The American Journal of Gastroenterology|January 31, 2025
HIV Infection Is Associated With a Less Aggressive Phenotype of Inflammatory Bowel Disease: A Multicenter Study of the ENEIDA RegistryMargalida Calafat, Carles Suria, Francisco Mesonero, et al.
The American Journal of Gastroenterology|November 26, 2024
Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study)María José García, Yanire Brenes, Miren Vicuña, et al.
Gastroenterologia Y Hepatologia|November 25, 2023
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)Diego Casas Deza, Ana Belén Julián Gomara, Eva Caudevilla Biota, et al.
Scandinavian Journal of Gastroenterology|October 22, 2010
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)Miguel A Montoro, Lawrence J Brandt, Santos Santolaria, et al.
Journal of Crohn'S & Colitis|November 20, 2019
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical TreatmentMichel Adamina, Stefanos Bonovas, Tim Raine, et al.
Journal of Clinical Medicine|July 2, 2021
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort StudyAhmad Albshesh, Joshua Taylor, Edoardo V Savarino, et al.
Digestive Diseases and Sciences|July 17, 2020
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA RegistryAlicia Algaba, Iván Guerra, Elena Ricart, et al.
Journal of Crohn'S & Colitis|October 9, 2025
Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkersMontse Baldán-Martín, Ibon Iloro, Mikel Azkargorta, et al.
Gastroenterologia Y Hepatologia|January 14, 2024
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)Diego Casas Deza, Ana Belén Julián Gomara, Eva Caudevilla Biota, et al.
The American Journal of Gastroenterology|July 15, 2024
HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study of the ENEIDA registryMargalida Calafat, Carles Suria, Francisco Mesonero, et al.
Pageof 57